Welcome and Introduction. Evolving landscape of Alzheimer’s disease
Exploring novel pathological pathways as potential treatment targets
Upcoming biomarkers for the diagnosis of early Alzheimer’s disease: Are we there yet?
Estimating meaningful benefit of treatment in Alzheimer’s disease
Panel discussion and Audience Q&A
Summary and Closing